News, trends, and stories from the synthetic biology industry

Hi all,


Thank you to Conagen for sponsoring this week's newsletter. Earlier this year, I wrote about Conagen’s breakthrough production of lactoferrin, a milk protein crucial to infant nutrition. Now, Conagen is tackling two more compounds found in breast milk.

In Covid-19 news, Ginkgo Bioworks and Octant announced a partnership to open a new processing facility in the San Francisco Bay Area that will deploy Octant’s SwabSeq sequencing platform and Next-Generation Sequencing (NGS) technology, initially capable of running up to 10,000 SARS-CoV-2 diagnostic tests per day.

In funding news:

Here's my latest for Forbes:

What if you could change your immune system by wearing earbuds? Meet the startup that could make it possible
Non-invasive, wearable tech could usher in a new generation of personalized therapeutics. Startup Nēsos aims to treat rheumatoid arthritis by reinforcing the brain’s natural pathways.

Building customer awareness for the next biotech startup: lessons from Brands & Biology
At SynBioBeta’s Brands and Biology event, entrepreneurs and innovators gathered from across the synthetic biology space to debate and develop solutions to the challenge of bringing biotech to consumers.

Have a great week,


Latest News

Will cell-based meat ever be a dinner staple? (Nature News)

How Aanika plans to revolutionize the multi-billion dollar food & agricultural insurance industry (Medium)

Researchers made golden rice extra gold with CRISPR (Massive Science)

2020 was the turning point for CRISPR (Future Human)

FDA approves genetically altering pigs, to potentially make food, drugs, and transplants safer (STAT News)

30 great gifts for biologically inspired people (NEO.LIFE)

GenScript granted authorization for cPass™ SARS-CoV-2 neutralization antibody detection test in Brazil (Press release)

CRISPR Therapeutics receives grant to advance in vivo CRISPR/Cas9 gene editing therapies for HIV (Press release)

CATALOG hires key scientists, names advisory board to advance DNA computing and storage (Press release)

Synthetic biology 2020–2030: six commercially-available products that are changing our world (Nature Communications)

What’s on the GMO menu: fast-growing salmon and slow-swimming tuna (MIT Technology Review)

Gene editing has made pigs immune to a deadly epidemic (MIT Technology Review)

A biotech insect repellent, safe enough to eat (Nature Biotech)

VIB and the Tianjin Institute of Industrial Biotechnology join forces in the TIB-VIB Joint Center of Synthetic Biology (TV-SynBio)

Pheronym signed a 5-year Cooperative Research and Development Agreement (CRADA) with the USDA (Press release)

Synlogic's SYNB1891 has advanced into the combination therapy stage of the ongoing Phase 1 trial (Press release)

Who's hiring?

Account Executive: Inscripta – UK and BNL


Scientist (Enzyme Engineering): Inscripta – Pleasanton, CA


Staff Scientist (Mammalian Cell Biology): Inscripta – Boulder, CO


Principal Synthetic Biologist: MITRE – McLean, VA


Principal Computational Systems Biologist: MITRE – McLean, VA


Biologist: Cambridge Consultants – Boston


Research Associate/Analyst: Johns Hopkins Center for Health Security – Baltimore, Maryland


Senior Scientist – Analytical Biochemistry: Inscripta – Pleasanton, California


University of California: Associate Teaching Professor of Bioengineering – Santa Cruz, California


Application Scientist: Codex DNA – San Diego, California


Scientist, Metabolic Engineer: Conagen – Bedford, MA


Scientist, Fungal Biology: Conagen – Bedford, MA


Scientist, Synthetic Biologist: Novome Biotechnologies – South San Francisco, CA


Biomolecular Nanomaterials Scientist: Berkeley Lab – Bay Area, CA


Graphic Designer: SynBioBeta (contractor)


Senior Scientist, Biochemistry: Inscripta – Pleasanton, CA

Feature your job here